Insider Trading, Goldman, Carlyle, Ally, TD in Court News
Bloomberg
By Elizabeth Amon
January 19, 2012
…Johnson & Johnson [JNJ] officials hid three studies showing some patients using Risperdal developed diabetes while claiming the antipsychotic drug didn’t cause the disease, a witness testified. As early as 1999, Johnson & Johnson’s Janssen unit had researchers’ findings that about half the patients taking Risperdal in a study comparing its risks to those of Eli Lilly & Co.’s Zyprexa antipsychotic drug developed diabetes after a year on the medication, Joseph Glenmullen, a psychiatrist and Harvard Medical School instructor, told a Texas jury yesterday. That study concluded Risperdal caused “medically serious weight gain” that led study subjects to develop diabetes, Glenmullen testified in the trial of the state of Texas’s lawsuit over Janssen’s marketing of the drug. At the same time, Janssen salespeople were telling doctors that researchers concluded the drug didn’t cause the disease, Glenmullen added.Texas contends New Brunswick, New Jersey-based J&J, the world’s largest health-care products company, defrauded the Medicaid program by promoting Risperdal for uses not approved by U.S. regulators, including for children with psychiatric disorders, and misleading doctors and regulators about the drug’s risks. The state joined a lawsuit filed by a whistle-blower, Allen Jones, a former Pennsylvania health-care fraud investigator. Lawyers for Texas Attorney General Greg Abbott are asking jurors in state court in Austin, Texas, to order J&J and Janssen to pay at least $579 million in damages over the companies’ Risperdal marketing practices.
Michael Clements, a Janssen spokesman, didn’t return a call for comment yesterday on Glenmullen’s testimony about the company’s handling of the studies. Glenmullen, testifying as an expert for the state, told jurors Janssen officials didn’t turn over Study 113, which found Risperdal posed a higher diabetes risk than Zyprexa, to the U.S. Food and Drug Administration when regulators began probing links between anti-psychotic medications and the disease in 2000. The drugmaker also didn’t turn over the results of two other later studies that found Risperdal and Zyprexa posed comparable diabetes risks to the FDA.
J&J Said to Settle Texas Risperdal Anti-Psychotic Drug Case
Bloomberg
By Jef Feeley and Margaret Cronin Fisk
January 19, 2012, 10:23 AM EST
Johnson & Johnson agreed to settle Texas officials’ claims that the drugmaker fraudulently marketed its Risperdal anti-psychotic drug and end a trial over the allegations, people familiar with the case said. The settlement will be announced in court today, the people said.
How can I be of more service to victims?
Also, any way I can get paid?
I am whistle-blower,victim advocate and victim took Zyprexa for 4 years got diabetes.www.zyprexa-victims.com
Google – Haszard Zyprexa
Google – Haszard Risperdal
Google – Haszard Seroquel
I have been fighting for 7 years made 150,000 critical pages,you would think Eli Lilly would pay me my justified Zyprexa claim to make me go away.
http://www.zyprexa-victims.com
just showed up on twitter: pharmalot: Johnson & Johnson to settle charges brought by Texas AG of illegally promoting Risperdal: sources.. announcement due shortly.. details tk
Is this just another “the cost of running a criminal enterprise” move…a jury verdict was desperately needed in this case. If J&J walks away without admitting guilt in this case (No matter what the settlement dollar amount), we the citizens have been robbed of justice, and this corporate system of rampant profiteering & corruption will continue unabated (if anyone hasn’t noticed: the widening approval & marketing of these drugs is still goes on as we read these news reports and blogs)…J&J was just the tip of the iceberg after all..
I sincerely hope I’m not the only one angry, sick, & tired of backroom deals and secrecy when it comes to these crimes that have destroyed countless victims lives….where is their justice?
Answer: NO WHERE TO BE FOUND!!!
SO WHAT HAS REALLY CHANGED? I suspect, very little….very little indeed…
http://www.pharmalot.com/2012/01/jj-pays-158m-to-settle-risperdal-lawsuit-in-texas/ Pharmalot J&J Pays $158M To Settle Risperdal Lawsuit In Texas
WOW…158 million dollar settlement….crime pays off huge if your a criminal corporation in America….make many billions…pay a few million…astonishing…….mind boggling….the corrupt game is absolutely rigged…
This seems more than a “normal” cost of doing business but J&J got off easy. One hopes the corporation is chastened and that they will change their behavior… shareholders won’t like it that they just pissed away 158M!
Stan’s right. What irks me is that the majority of docs prescribing this stuff (to people who really never should have received it in the first place) are blissfully unaware of these events. To them, it’s as if nothing has changed….
Well, at least one psychiatrist here who will write for even less risperidone than did prior. One thing $158 mill won’t pay for: justice!
$158 million. Texas was asking for $579M
No jail time for the executives who lead all this illegal activity? Then, no justice.